Data / Drug companies / Polyene Antifungal
Polyene Antifungal drugs: 8 drugs from 53 companies in the FDA NDC directory
Polyene Antifungal is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 133 products in this class from 53 companies, covering 8 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on July 6, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 53Companies
- 133Products
- 8Drugs by generic name
Drugs in the Polyene Antifungal class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Nystatin | 82 | 40 |
| Nystatin and triamcinolone acetonide | 28 | 18 |
| Nystatin, triamcinolone acetonide | 7 | 5 |
| Nystatin cream | 5 | 5 |
| Amphotericin b | 5 | 4 |
| Nystatin ointment | 2 | 2 |
| Nystatin topical powder | 3 | 1 |
| Amphotericin b liposome | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 15 | ointment; cream | Generic drugs (ANDA) | August 14, 2020 |
| Bryant Ranch Prepack | 10 | cream; ointment | Generic drugs (ANDA) | August 25, 2021 |
| A-S Medication Solutions | 8 | cream; suspension | Generic drugs (ANDA) | July 17, 2020 |
| NuCare Pharmaceuticals,Inc. | 8 | cream; tablet, coated | Generic drugs (ANDA) | December 5, 2022 |
| Preferred Pharmaceuticals Inc. | 7 | cream; tablet, coated | Generic drugs (ANDA) | July 6, 2026 |
| Bryant Ranch Prepack | 6 | cream; powder | Generic drugs (ANDA) | September 28, 2019 |
| Macleods Pharmaceuticals Limited | 4 | cream; ointment | Generic drugs (ANDA) | August 31, 2022 |
| Padagis Israel Pharmaceuticals Ltd | 4 | cream; ointment | Generic drugs (ANDA) | November 27, 2017 |
| Epic Pharma, LLC | 3 | powder | Generic drugs (ANDA) | April 14, 2023 |
| Leading Pharma, LLC | 3 | ointment; powder | Generic drugs (ANDA) | December 5, 2022 |
| Proficient Rx LP | 3 | cream; ointment | Generic drugs (ANDA) | September 21, 2006 |
| Proficient Rx LP | 3 | ointment; tablet, coated | Generic drugs (ANDA) | October 6, 2017 |
| Sun Pharmaceutical Industries, Inc. | 3 | cream; ointment | Generic drugs (ANDA) | March 29, 1993 |
| Torrent Pharmaceuticals Limited | 3 | cream; ointment | Generic drugs (ANDA) | July 14, 2020 |
| Zydus Lifesciences Limited | 3 | ointment; powder | Generic drugs (ANDA) | October 6, 2021 |
| Alembic Pharmaceuticals Inc. | 2 | cream; ointment | Generic drugs (ANDA) | March 15, 2022 |
| Cardinal Health 107, LLC | 2 | suspension | Generic drugs (ANDA) | July 17, 2020 |
| Chartwell RX, LLC | 2 | tablet, film coated; suspension | Generic drugs (ANDA) | October 31, 2011 |
| Cosette Pharmaceuticals, Inc. | 2 | cream; ointment | Generic drugs (ANDA) | October 6, 2017 |
| Crown Laboratories | 2 | cream | Generic drugs (ANDA) | January 2, 2018 |
| Direct_Rx | 2 | cream | Generic drugs (ANDA) | January 5, 2023 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 2 | injectable, liposomal; tablet, coated | Generic drugs (ANDA) | June 20, 2025 |
| Kesin Pharma Corporation | 2 | suspension | Generic drugs (ANDA) | August 14, 2020 |
| NuCare Pharmaceuticals, Inc. | 2 | cream | Generic drugs (ANDA) | September 21, 2006 |
| Redpharm Drug | 2 | cream | Generic drugs (ANDA) | July 24, 2019 |
| Sun Pharmaceutical Industries, Inc. | 2 | injectable, liposomal | Generic drugs (ANDA) | December 1, 2024 |
| Viona Pharmaceuticals Inc | 2 | ointment | Generic drugs (ANDA) | June 24, 2020 |
| Actavis Pharma, Inc. | 1 | ointment | Generic drugs (ANDA) | September 3, 2002 |
| Alembic Pharmaceuticals Limited | 1 | cream | Generic drugs (ANDA) | April 8, 2025 |
| American Health Packaging | 1 | suspension | Generic drugs (ANDA) | February 26, 2024 |
| Atlantic Biologicals Corp. | 1 | suspension | Generic drugs (ANDA) | December 5, 2022 |
| Aurobindo Pharma Limited | 1 | cream | Generic drugs (ANDA) | March 21, 2025 |
| AvKARE | 1 | tablet, film coated | Generic drugs (ANDA) | January 20, 2014 |
| Chartwell Governmental & Specialty RX, LLC. | 1 | suspension | Authorized generics (NDA) | April 14, 1971 |
| Dr. Reddy's Laboratories Inc. | 1 | powder | Generic drugs (ANDA) | May 28, 2024 |
| Encube Ethicals, Inc. | 1 | ointment | Generic drugs (ANDA) | September 28, 2019 |
| Eugia US LLC | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | November 17, 2022 |
| Genus Lifesciences | 1 | suspension | Generic drugs (ANDA) | March 24, 2026 |
| Glenmark Pharmaceuticals Inc., USA | 1 | ointment | Generic drugs (ANDA) | June 23, 2016 |
| Kanchan Healthcare Inc | 1 | suspension | Generic drugs (ANDA) | August 14, 2020 |
| Lupin Pharmaceuticals, Inc. | 1 | cream | Generic drugs (ANDA) | November 29, 2018 |
| Major Pharmaceuticals | 1 | suspension | Generic drugs (ANDA) | July 17, 2020 |
| Mylan Institutional LLC | 1 | injection, powder, lyophilized, for suspension | Generic drugs (ANDA) | August 6, 2025 |
| NorthStar RxLLC | 1 | powder | Generic drugs (ANDA) | September 1, 2025 |
| Padagis US LLC | 1 | powder | Generic drugs (ANDA) | August 16, 1996 |
| Pai Holdings, LLC DBA Pai Pharma | 1 | suspension | Generic drugs (ANDA) | July 17, 2020 |
| Proficient Rx LP | 1 | cream | Generic drugs (ANDA) | July 24, 2019 |
| Remedyrepack Inc. | 1 | cream | Generic drugs (ANDA) | April 12, 2018 |
| Teva Pharmaceuticals USA, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | September 30, 1990 |
| Upsher-Smith Laboratories, LLC | 1 | powder | Generic drugs (ANDA) | May 3, 2005 |
| XGen Pharmaceuticals DJB, Inc. | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 29, 1992 |
| Xttrium Laboratories, Inc. | 1 | suspension | Generic drugs (ANDA) | February 6, 2026 |
| Zydus Pharmaceuticals USA Inc. | 1 | powder | Generic drugs (ANDA) | October 6, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 53 | 39.8% |
| Ointment | 30 | 22.6% |
| Suspension | 20 | 15% |
| Powder | 16 | 12% |
| Tablet, coated | 5 | 3.8% |
| Injectable, liposomal | 3 | 2.3% |
| Tablet, film coated | 3 | 2.3% |
| Injection, powder, lyophilized, for solution | 2 | 1.5% |
| Injection, powder, lyophilized, for suspension | 1 | 0.8% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.